Rex D. Geveden, President and CEO of BWX Technologies, Inc., filed a Form 4 on August 13, 2026, disclosing the sale of common stock across four separate transactions executed on August 12, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Four sales on one date: Geveden disposed of shares in four separate transactions on August 12, 2026, totaling 2,407, 4,730, 263, and 2,600 shares respectively.
  • Weighted average prices: The four transactions carried weighted average prices of $171.2147, $172.1796, $172.9971, and $174.225 per share.
  • Post-transaction ownership: Following all four sales, Geveden directly held 192,491 shares of BWX Technologies common stock.
  • 10b5-1 plan: According to the filing, the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Geveden on August 11, 2025.
  • Reporting person's role: Geveden is identified in the filing as both a Director and the President and CEO of BWX Technologies, listed on the NYSE as BWXT.

Details of Geveden's August 2026 Share Sales at BWX Technologies

According to the Form 4 filed with the SEC, Rex D. Geveden sold BWX Technologies common stock in four distinct tranches on August 12, 2026. The first tranche covered 2,407 shares at a weighted average price of $171.2147, with individual sale prices ranging from $170.6500 to $171.6300 inclusive. The second tranche involved 4,730 shares at a weighted average of $172.1796, with prices ranging from $171.6700 to $172.6000. BWX Technologies is a company whose common stock trades on the NYSE under the ticker BWXT.

The third tranche comprised 263 shares at a weighted average price of $172.9971, with prices ranging from $172.8200 to $173.6900 inclusive. The fourth and final tranche covered 2,600 shares at a weighted average price of $174.225, with prices ranging from $173.8500 to $174.2400. All four transactions were coded "S" in the filing, indicating open-market sales of directly held shares. The filing notes that full pricing detail for each separate transaction price is available upon request by the SEC staff, the issuer, or any security holder.

The filing states that all sales were made pursuant to a Rule 10b5-1 trading plan that Geveden adopted on August 11, 2025, approximately one year before the reported transactions. Rule 10b5-1 plans allow corporate insiders to establish pre-scheduled trading arrangements at a time when they are not in possession of material nonpublic information. No derivative securities transactions were reported in Table II of this filing. The Form 4 was signed on August 13, 2026, by Alexander D. Cobey as attorney-in-fact for Geveden.

What Was Disclosed

The filing reports the direct sale of a combined 10,000 shares of BWX Technologies common stock by its President and CEO across four transactions on August 12, 2026, all conducted under a pre-existing Rule 10b5-1 plan, leaving him with 192,491 directly held shares.